Business and IChemE news related to Biochemical Engineering including biopharm, Cell & gene therapy and industrial biotech.
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement
Valneva today announced that it has received a notice from the European Commission (“EC”) of intent to terminate the advance purchase agreement (“APA”) for Valneva’s inactivated whole-virus COVID-1...
GV, Sanofi drive British biotech OMass to $100M series B
GV, Northpond Ventures and Sanofi Ventures have joined forces to pump $100 million into OMass Therapeutics, teeing the British biotech up to advance candidates against hard-to-hit targets toward th...
Thermo Fisher Scientific Expands R&D Facility in India
Thermo Fisher Scientific announced on April 28, 2022 that it has expanded its new R&D and engineering facility, India Engineering Center (IEC) in Hyderabad, India.
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Valneva and Pfizer today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15.
Catalent to Invest $350 Million in Manufacturing Facility in Bloomington
Catalent announced on April 21, 2022 that it is planning a multi-year $350 million investment at its facility in Bloomington, Ind. to expand its biologics drug substance and drug product manufactur...
Achilles Therapeutics Announces Manufacturing Expansion in the UK and US
Achilles Therapeutics, a clinical-stage biopharmaceutical company, announced on April 12, 2022 that it is expanding its clinical manufacturing capabilities in the United Kingdom and the United States.
Catalent Acquires VMIC Facility in Oxfordshire
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, toda...
KeyPlants Ships First-of-its-Kind Vaccine Manufacturing Facility to Africa
KeyPlants, a Swedish provider of innovative life science facilities and PODs, announced on March 29, 2022 that it has shipped a first-of-its-kind vaccine manufacturing filling facility to Senegal i...
Moderna finalizes strategic partnership with Australian government
Moderna, Inc today announced the finalisation of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility in Aust...
Silence stops enrollment in blood cancer arm of RNAi trial
Silence Therapeutics’ stuttering effort to generate clinical data on SLN124 in myelodysplastic syndrome (MDS) has conked out.
Investor Donald Houston backs Scottish biofuel push
Ardnamurchan Distillery, Woodlands Renewables and Celtic Renewables have joined forces to accelerate the launch of what they describe as potentially world-beating biofuel technology.